Cohort Company News - MedTech Innovator

Nutromics won in the category of ‘Technology Platform Solution of the Year’ at the AIIA’s 2021 national iAwards!

DateSep 09 2021

We are excited to announce that last night Nutromics won in the category of 'Technology Platform Solution of the Year' at the AIIA's 2021 national iAwards!

InBrace Raises $102M Series D Financing

DateSep 08 2021

InBrace, the orthodontic company behind the novel Smartwire™ category of behind-the-teeth, teeth straightening, today announced the closing of an oversubscribed $102 million Series D financing by funds affiliated with new investor groups co-led by Farallon Capital Management, L.L.C. and Marshall Wace.

Stryker Acquires Med Device Company Gauss Surgical

DateSep 07 2021

Stryker today announced the acquisition of Gauss Surgical, a Menlo Park, CA-based medical device company that has developed Triton™, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery.

Sentien Biotechnologies Partners with BARDA to Evaluate High Dose Cohort in Phase 1/2 Trial of SBI-101 for Treatment of Acute Kidney Injury Associated with Sepsis

DateSep 02 2021

Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA).

Onkos Surgical raises $15M Series C

DateSep 01 2021

Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopedic procedures based in Parsippany, announced Wednesday that it has raised $15 million in Series C funding from its existing investor syndicate.

Australian medtech startup Nutromics bags $4M in pre-market funding for continuous molecular monitoring device

DateAug 27 2021

Nutromics, an Australian medical technology startup, has raised A$5.7 million ($4.1 million) in a pre-market funding round participated by private investors. This brings its total capital raised in the past three years to A$10 million ($7.2 million).

Eclipse Regenesis Awarded National Institutes of Health (NIH) Grant

DateAug 26 2021

Eclipse Regenesis, Inc., developer of the first restorative therapy to address pediatric and adult Short Bowel Syndrome, has been awarded a National Institutes of Health Small Business Innovation Research (NIH SBIR) Fast Track grant of $1.7 million.

Genetesis Announces New Scientific Advisory Board

DateAug 26 2021

Genetesis, the market leader in the design, development and commercialization of biomagnetic imaging solutions, today announced its new Scientific Advisory Board (SAB).

Trinity Health Mid-Atlantic teams with NeuroFlow to offer mental health app to workers

DateAug 25 2021

Independence Blue Cross Foundation is teaming up with Trinity Health Mid-Atlantic and health tech company NeuroFlow to support its workers’ mental health.

BrainSightAI Raises $750,000 Seed

DateAug 24 2021

Bengaluru-based deep-tech neuroscience startup BrainSightAI announced on Tuesday that it has raised $750,000 in a Seed round led by Stanford Angels & Entrepreneurs India with participation from Entrepreneur First, Red Start Labs and IKP Knowledge Park.

Lightpoint Medical and Telix Pharmaceuticals Announce Strategic Collaboration Agreement

DateAug 23 2021

Lightpoint Medical, a leading medical device company developing and marketing miniaturized imaging and sensing tools for minimally-invasive and robot-assisted surgery, announced today that it has signed a strategic collaboration agreement with Telix Pharmaceuticals Limited.

1st Covid Vaccine For Children Above 12 Approved In India, featuring PharmaJet

DateAug 21 2021

India's drug regulator on Friday approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country.

CloudCath, American Renal Associates Partner on Dialysis Study

DateAug 20 2021

CloudCath, developer of a remote monitoring and predictive analytics platform for catheter-based treatments, is collaborating with American Renal Associates (ARA), a leading provider of outpatient dialysis services.

Scancell Holdings PLC to use needle-free technology for next-generation vaccine candidates, featuring PharmaJet

DateAug 17 2021

Scancell Holdings PLC (AIM:SCLP, FRA:SCP) (AIM:SCLP) said it will use PharmaJet’s needle-free technology to administer Covid vaccine candidates SCOV1 and SCOV2 in its COVIDITY phase I clinical trial.

Ischemia Care Launches Gene Signature LDT to Detect and Differentiate Stroke

DateAug 17 2021

Ischemia Care Launches Gene Signature LDT to Detect and Differentiate Stroke.

Auctus Surgical: FDA Breakthrough Device Designation, Key Patent for Non-Fusion Scoliosis System

DateAug 11 2021

Auctus Surgical, a company devoted to non-fusion options for scoliosis patients, is developing a one-of-a-kind vertebral body tethering (VBT) system to treat pediatric scoliosis with a non-fusion, dynamic approach.

Koya Medical Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms

DateAug 10 2021

Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active compression therapy system for lymphedema—Dayspring™— was issued new billing codes by the Center of Medicare & Medicaid Services (CMS) in accordance with the Healthcare Common Procedure Coding System (HCPCS).

Encellin Closes $5.9M Seed Co-Led by Khosla Ventures and SV Latam Capital

DateAug 05 2021

Encellin, a personalized regenerative medicine biotech company developing novel cell-based approaches to deliver sustained therapies with a single implant, today announced the closing of a $5.9M Seed financing round.

EchoNous Partners with Us2.ai for Machine Learning-enabled Analysis of Heart Scans

DateAug 05 2021

EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements.

Embody Announces $20.5M Funding Round

DateAug 04 2021

Embody, Inc., a privately-held medical device company focused on soft tissue healing, announced today that it has secured $11.5 million in an oversubscribed equity financing.